DIFFERENCES IN CARDIOVASCULAR PROFILE AMONG CALCIUM-ANTAGONISTS

[21] INHIBITION OF CYCLIC-AMP PHOSPHODIESTERASE BY 2,6-DIMETHYL-4-(3-NITROPHENYL)-1,4-DIHYDROPYRIDINE-3,5-DICARBOXYLIC ACID 3-[2-(N-BENZYL-N-METHYLAMINO)] ETHYL-ESTER 5-METHYL ESTER HYDROCHLORIDE (YC-93), A POTENT VASODILATOR [J]. BIOCHEMICAL PHARMACOLOGY, 1978, 27 (08) : 1269 - 1274

[22] SATOH K, 1984, ARZNEIMITTEL-FORSCH, V34-1, P563

[23] SATOH K, 1986, ARZNEIMITTELFORSCH, V36-1, P35

[24] MECHANISMS UNDERLYING THE CARDIOVASCULAR ACTION OF A NEW DIHYDROPYRIDINE VASODILATOR, YC-93 [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1980, 7 (03): : 249 - 262

[25] CARDIAC VERSUS CORONARY VASODILATOR ACTIONS OF KB-944, A NEW CALCIUM-ANTAGONIST, ASSESSED IN ISOLATED, BLOOD-PERFUSED HEART PREPARATIONS OF DOGS [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1983, 5 (03) : 349 - 356

[26] TAIRA N, 1979, NEW DRUG THERAPY CAL, P91

[27] TAKAHASHI K, 1986, ARZNEIMITTELFORSCH, V36-2, P1054

[28] CALCIUM CHANNELS IN EXCITABLE CELL-MEMBRANES [J]. ANNUAL REVIEW OF PHYSIOLOGY, 1983, 45 : 341 - 358

[29] CORONARY VASODILATOR COMPARED TO CARDIAC EFFECTS OF PY 108-068, A NEW DIHYDROPYRIDINE VASODILATOR, ON ISOLATED, BLOOD-PERFUSED DOG-HEART PREPARATIONS [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1984, 6 (05) : 881 - 887

[30] SEPARATION OF THE CORONARY VASODILATOR FROM THE CARDIAC EFFECTS OF PN-200-110, A NEW DIHYDROPYRIDINE CALCIUM-ANTAGONIST, IN THE DOG HEART [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1985, 7 (01) : 190 - 196

[21] INHIBITION OF CYCLIC-AMP PHOSPHODIESTERASE BY 2,6-DIMETHYL-4-(3-NITROPHENYL)-1,4-DIHYDROPYRIDINE-3,5-DICARBOXYLIC ACID 3-[2-(N-BENZYL-N-METHYLAMINO)] ETHYL-ESTER 5-METHYL ESTER HYDROCHLORIDE (YC-93), A POTENT VASODILATOR [J]. BIOCHEMICAL PHARMACOLOGY, 1978, 27 (08) : 1269 - 1274

[22] SATOH K, 1984, ARZNEIMITTEL-FORSCH, V34-1, P563

[23] SATOH K, 1986, ARZNEIMITTELFORSCH, V36-1, P35

[24] MECHANISMS UNDERLYING THE CARDIOVASCULAR ACTION OF A NEW DIHYDROPYRIDINE VASODILATOR, YC-93 [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1980, 7 (03): : 249 - 262

[25] CARDIAC VERSUS CORONARY VASODILATOR ACTIONS OF KB-944, A NEW CALCIUM-ANTAGONIST, ASSESSED IN ISOLATED, BLOOD-PERFUSED HEART PREPARATIONS OF DOGS [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1983, 5 (03) : 349 - 356

[26] TAIRA N, 1979, NEW DRUG THERAPY CAL, P91

[27] TAKAHASHI K, 1986, ARZNEIMITTELFORSCH, V36-2, P1054

[28] CALCIUM CHANNELS IN EXCITABLE CELL-MEMBRANES [J]. ANNUAL REVIEW OF PHYSIOLOGY, 1983, 45 : 341 - 358

[29] CORONARY VASODILATOR COMPARED TO CARDIAC EFFECTS OF PY 108-068, A NEW DIHYDROPYRIDINE VASODILATOR, ON ISOLATED, BLOOD-PERFUSED DOG-HEART PREPARATIONS [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1984, 6 (05) : 881 - 887

[30] SEPARATION OF THE CORONARY VASODILATOR FROM THE CARDIAC EFFECTS OF PN-200-110, A NEW DIHYDROPYRIDINE CALCIUM-ANTAGONIST, IN THE DOG HEART [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1985, 7 (01) : 190 - 196